Search over 3,000 reports

    Urinary Incontinence - Market Insights, Epidemiology and Market Forecast -2023-7MM

    Urinary Incontinence - Market Insights, Epidemiology and Market Forecast -2023-7MM
    Date: Nov, 2017
    Type: Pharmaceutical Industry Report
    Pages: 77
    Geography: Global
    Delivery Timeline: 24 Hours
    SKU: DIMI0006
    DelveInsight's "Urinary Incontinence - Market Insights, Epidemiology and Market Forecast-2023-7MM" Reports provides an overview of the disease and global market size of the Urinary Incontinence for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Urinary Incontinence from 2013-2023.
    Urinary Incontinence is a multifactorial syndrome which occurs due to the failure of the storage function of the lower urinary tract and loss of bladder control resulting in leakage of urine. Embarrassment, isolation, and depression are observed among patients with Urinary Incontinence. Millions of individuals worldwide are suffering from Urinary Incontinence. It is most common among the old people. It increases the chances of developing several medical conditions such as local skin irritation, rashes, and urinary infections.
    According to DelveInsight, the market size for Urinary Incontinence of 7 MM is estimated to be USD XX Million by 2023 at a CAGR of 9.5% for the forecast period i.e., 2013-2023.
    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
    Scope
    The report will help in developing business strategies by understanding the trends shaping and driving the Urinary Incontinence market.
    Organize sales and marketing efforts by identifying the best opportunities for Urinary Incontinence in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.
    To understand the future market competition in the 7MM market of Urinary Incontinence and Insightful review of the key market drivers and barriers.
    To understand the regulatory scenario in major markets.

    The Report also covers the detailed historical and forecasted Urinary Incontinence market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.
    Report Introduction
    Urinary Incontinence Market Overview at a Glance
    7 MM Market Size of Urinary Incontinence (2013-2023)
    Total Market Share Distribution of Urinary Incontinence for 7 MM in 2016
    Total Market Share Distribution of Urinary Incontinence for 7 MM in 2023
    Urinary Incontinence
    Overview
    Pathophysiology
    Etiology
    Risk factors
    Diagnosis
    Treatment
    Epidemiology and Patient Population
    Total number of Prevalent cases - 7MM Countries - (2016 & 2023)
    Secondary Studies referred
    United States
    Prevalent Cases of Urinary Incontinence in United States
    Percentage Distribution ofUrinary Incontinence by Sub Types
    Germany
    Prevalent Cases of Urinary Incontinence in Germany
    Percentage Distribution ofUrinary Incontinence by Sub Types
    France
    Prevalent Cases of Urinary Incontinence in France
    Percentage Distribution ofUrinary Incontinence by Sub Types
    United Kingdom
    Prevalent Cases of Urinary Incontinence in United Kingdom
    Percentage Distribution ofUrinary Incontinence by Sub Types
    Spain
    Prevalent Cases of Urinary Incontinence in Spain
    Percentage Distribution ofUrinary Incontinence by Sub Types
    Italy
    Prevalent Cases of Urinary Incontinence in Italy
    Percentage Distribution ofUrinary Incontinence by Sub Types
    Japan
    Prevalent Cases of Urinary Incontinence in Japan
    Percentage Distribution ofUrinary Incontinence by Sub Types
    Treatment Algorithm
    Current Unmet Needs
    Marketed Drugs
    Major Marketed Drugs
    Myrbetriq\ Betmiga\Betani
    Description
    Regulatory Milestones
    Advantages and Disadvantages
    Product Profile
    Efficacy
    Safety
    Side effects
    Botox
    Description
    Regulatory Milestones
    Advantages and Disadvantages
    Product Profile
    Efficacy
    Safety
    Side effects
    Toviaz
    Description
    Regulatory Milestones
    Advantages and Disadvantages
    Product Profile
    Efficacy
    Safety
    Side effects
    VESIcare
    Description
    Regulatory Milestones
    Advantages and Disadvantages
    Product Profile
    Efficacy
    Safety
    Side effects
    Emerging Therapies
    Key Emerging Therapies
    Vibegron: Kissei Pharmaceutical Co., Ltd.
    Product Development Activities
    Clinical Development
    Product Profile
    Clinical Trial by Phase
    AbobotulinumtoxinA: Ipsen Group
    Clinical Development
    Product Profile
    Clinical Trial by Phase
    Mirabegron+Solifenacin: Astellas Pharma Inc.
    Product Development Activities
    Clinical Development
    Product Profile
    Clinical Trial by Phase
    Global Urinary Incontinence: Country-Wise Market Analysis
    Overview on Total Urinary Incontinence Market (2016)
    Overview on Total Urinary Incontinence Market (2023)
    Global Urinary incontinence: Market Analysis
    United States Market Size
    Europe Market Size
    Germany Market Size
    France Market Size
    United Kingdom Market Size
    Spain Market Size
    Italy Market Size
    Japan Market Size
    Market Drivers
    Market Barriers
    Report Methodology
    Consulting Services
    Disclaimer
    About DelveInsight

    Table 1: 7 MM Market Size of Urinary Incontinence in USD Million (2013-2023)
    Table 2: Prevalent Cases Urinary Incontinence in United States (2013-2023)
    Table 3: Percentage Distribution of Urinary Incontinence by Sub Types in United States (2016)
    Table 4: Prevalent Cases Urinary Incontinence in Germany (2013-2023)
    Table 5: Percentage Distribution of Urinary Incontinence by Sub Types in Germany (2016)
    Table 6: Prevalent Cases Urinary Incontinence in France (2013-2023)
    Table 7: Percentage Distribution of Urinary Incontinence by Sub Types in France (2016)
    Table 8: Prevalent Cases Urinary Incontinence in United Kingdom (2013-2023)
    Table 9: Percentage Distribution of Urinary Incontinence by Sub Types in United Kingdom (2016)
    Table 10: Prevalent Cases Urinary Incontinence in Spain (2013-2023)
    Table 11: Percentage Distribution of Urinary Incontinence by Sub Types in Spain (2016)
    Table 12: Prevalent Cases Urinary Incontinence in Italy (2013-2023)
    Table 13: Percentage Distribution of Urinary Incontinence by Sub Types in Italy (2016)
    Table 14: Prevalent Cases Urinary Incontinence in Japan (2013-2023)
    Table 15: Percentage Distribution of Urinary Incontinence by Sub Types in Japan (2016)
    Table 16: Marketed Drugs for Urinary Incontinence
    Table 17: Emerging Therapies for Urinary Incontinence
    Table 18: Total Urinary Incontinence , Distribution share (2016) as per the 7MM
    Table 19: Total Urinary Incontinence , Distribution share (2023) as per the 7MM
    Table 20: United States Market Size of Urinary Incontinence in USD, Million (2013-2023)
    Table 21: Germany Market Size of Urinary Incontinence in USD, Million (2013-2023)
    Table 22: France Market Size of Urinary Incontinence in USD, Million (2013-2023)
    Table 23: United Kingdom Market Size of Urinary Incontinence in USD, Million (2013-2023)
    Table 24: Spain Market Size of Urinary Incontinence in USD, Million (2013-2023)
    Table 25: Italy Market Size of Urinary Incontinence in USD, Million (2013-2023)
    Table 26: Japan Market Size of Urinary Incontinence in USD, Million (2013-2023)
    Figure 1:Types of Urinary Incontinence
    Figure 2:Risk Factors of Urinary Incontinence
    Figure 3:Treatment of Urinary Incontinence
    Figure 4: Prevalent Cases of Urinary Incontinence in United States (2013-2023)
    Figure 5: Percentage Distribution ofUrinary Incontinence by Sub Types in United States (2016)
    Figure 6: Prevalent Cases of Urinary Incontinence in Germany (2013-2023)
    Figure 7: Percentage Distribution ofUrinary Incontinence by Sub Types in Germany (2016)
    Figure 8: Prevalent Cases of Urinary Incontinence in France (2013-2023)
    Figure 9: Percentage Distribution ofUrinary Incontinence by Sub Types in France (2016)
    Figure 10: Prevalent Cases of Urinary Incontinence in United Kingdom (2013-2023)
    Figure 11: Percentage Distribution ofUrinary Incontinence by Sub Types in United Kingdom (2016)
    Figure 12: Prevalent Cases of Urinary Incontinence in Spain (2013-2023)
    Figure 13: Percentage Distribution ofUrinary Incontinence by Sub Types in Spain (2016)
    Figure 14: Prevalent Cases of Urinary Incontinence in Italy (2013-2023)
    Figure 15: Percentage Distribution ofUrinary Incontinence by Sub Types in Italy (2016)
    Figure 16: Prevalent Cases of Urinary Incontinence in Japan (2013-2023)
    Figure 17: Percentage Distribution ofUrinary Incontinence by Sub Types in Japan (2016)
    Figure 18:Treatment algorithm for Children with Urinary Incontinence
    Figure 19:Treatment algorithm for Men with Urinary Incontinence
    Figure 20:Treatment algorithm for Women with Urinary Incontinence
    Figure 21: Total 7 Major Market Size of Urinary Incontinence in USD, Million (2016)
    Figure 22: Total 7 Major Market Size of Urinary Incontinence in USD, Million (2023)
    Figure 23: United States Market Size of Urinary Incontinence in USD, Million (2013-2023)
    Figure 24: Germany Market Size of Urinary Incontinence in USD, Million (2013-2023)
    Figure 25: France Market Size of Urinary Incontinence in USD, Million (2013-2023)
    Figure 26: United Kingdom Market Size of Urinary Incontinence in USD, Million (2013-2023)
    Figure 27: Spain Market Size of Urinary Incontinence in USD, Million (2013-2023)
    Figure 28: Italy Market Size of Urinary Incontinence in USD, Million (2013-2023)
    Figure 29: Japan Market Size of Urinary Incontinence in USD, Million (2013-2023)
    Figure 30: Market Drivers for Urinary Incontinence
    Figure 31: Market Barriers for Urinary Incontinence
    Urinary Incontinence Market (7MM)

    Urinary Incontinence Market forecasting

    Urinary Incontinence Sales forecasting

    Urinary Incontinence Market segments

    Urinary Incontinence Epidemiology

    Urinary Incontinence Pipeline products and technologies

    Urinary Incontinence Competitive landscape

    Urinary Incontinence SWOT analysis

    Urinary Incontinence Market Driver's and barriers

    Urinary Incontinence Key Companies and Funding

    • Single User License
      (20% Off)
      $4,950.00
      $3960
    • Site License
      (30% Off)
      $9,900.00
      $6930
    • Global License
      (40% Off)
      $14,850.00
      $8910

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap